Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris

BACKGROUND: Excess levels of serum acylcarnitines, which are intermediate products in metabolism, have been observed in metabolic diseases such as type 2 diabetes mellitus. However, it is not known whether acylcarnitines may prospectively predict risk of cardiovascular death or acute myocardial infa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Am Heart Assoc
Auteurs principaux: Strand, Elin, Pedersen, Eva R., Svingen, Gard F. T., Olsen, Thomas, Bjørndal, Bodil, Karlsson, Therese, Dierkes, Jutta, Njølstad, Pål R., Mellgren, Gunnar, Tell, Grethe S., Berge, Rolf K., Svardal, Asbjørn, Nygård, Ottar
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523736/
https://ncbi.nlm.nih.gov/pubmed/28159823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003620
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires